{{knowledge objective
|Identifiant=OIC-027-31-A
|Item_parent=Prevention of foetal risks: infection, drugs, toxic substances, irradiation
|Item_parent_short=Prevention of foetal risks: infection, drugs, toxic substances, irradiation
|Rank=A
|Intitulé=Médicaments et grossesse : connaître les principaux médicaments à risque
|Description=Knowing how to identify the main drugs at risk
|Rubric=Positive diagnosis
|Contributors=Alexandre Vivanti, Philippe Deruelle
|Order=31}}

{| class="wikitable"
|'''Family'''
|'''INN (trade name)'''
|-
|Vitamin A derivatives
|Isotretinoin

(Roaccutane<sup>®</sup>, Acnetrait<sup>®</sup>, Curacne<sup>®</sup>, Procuta<sup>®</sup>)

Acitretin

(Soriatane<sup>®</sup>)
|-
|Thymoregulator
|Lithium (Téralithe<sup>®</sup>)
|-
|Oral anticoagulants, antivitamins K
|Warfarin (Coumadin<sup>®</sup>)
|-
|Antiepileptics
|Sodium valproate (Depakine<sup>®</sup>), carbamazepine (Tegretol<sup>®</sup>)
|-
|Prostaglandin analogue (PGE1)
|Misoprostol (Gymiso<sup>®</sup>, Misoone<sup>®</sup>)
|-
|Immunosuppressant
|Mycophenolate (Cellcept<sup>®</sup>, Myfortic<sup>®</sup>)
|-
|Cancer treatment
|Methotrexate (Ledertrexate<sup>®</sup>, Imeth<sup>®</sup>)
|-
|Synthetic antithyroid drugs
|Carbimazole, (Neo-Mercazole<sup>®</sup>)

PTU (propylthio-uracil: Propylex<sup>®</sup>)
|-
|Virostatics
|Ribavirin (Copegus<sup>®</sup>, Rebetol<sup>®</sup>)

Efavirenz (Sustiva<sup>®</sup>)
|}


'''312. [[Prevention of foetal risks SD-312|Prevention of foetal risks]]''''

'''340 [[Voluntary or involuntary intake of a toxic or potentially toxic drug SD-340|Voluntary or involuntary intake of a toxic or potentially toxic drug]]''''

'''348. [Suspicion of an adverse drug reaction or an adverse drug treatment SD-348|Suspicion of an adverse drug reaction or an adverse drug treatment]'''''

'''352. [[Explaining treatment to the patient (adult/child/adolescent) SD-352|Explaining treatment to the patient (adult/child/adolescent)]]'''''